TY - JOUR
T1 - Cdc2/cyclin B1 interacts with and modulates inositol 1,4,5-trisphosphate receptor (type 1) functions
AU - Li, Xiaogui
AU - Malathi, Krishnamurthy
AU - Krizanova, Olga
AU - Ondrias, Karol
AU - Sperber, Kirk
AU - Ablamunits, Vitaly
AU - Jayaraman, Thottala
PY - 2005/11/1
Y1 - 2005/11/1
N2 - The resistance of inositol 1,4,5-trisphosphate receptor (IP 3R)-deficient cells to multiple forms of apoptosis demonstrates the importance of IP3-gated calcium (Ca2+) release to cellular apoptosis. However, the specific upstream biochemical events leading to IP 3-gated Ca2+ release during apoptosis induction are not known. We have shown previously that the cyclin-dependent kinase 1/cyclin B (cdk1/CyB or cdc2/CyB) complex phosphorylates IP3R1 in vitro and in vivo at Ser421 and Thr799. In this study, we show that: 1) the cdc2/CyB complex directly interacts with IP3R1 through Arg 391, Arg441, and Arg871; 2) IP3R1 phosphorylation at Thr799 by the cdc2/CyB complex increases IP 3 binding; and 3) cdc2/CyB phosphorylation increases IP 3-gated Ca2+ release. Taken together, these results demonstrate that cdc2/CyB phosphorylation positively regulates IP 3-gated Ca2+ signaling. In addition, identification of a CyB docking site(s) on IP3R1 demonstrates, for the first time, a direct interaction between a cell cycle component and an intracellular calcium release channel. Blocking this phosphorylation event with a specific peptide in inhibitor(s) may constitute a new therapy for the treatment of several human immune disorders.
AB - The resistance of inositol 1,4,5-trisphosphate receptor (IP 3R)-deficient cells to multiple forms of apoptosis demonstrates the importance of IP3-gated calcium (Ca2+) release to cellular apoptosis. However, the specific upstream biochemical events leading to IP 3-gated Ca2+ release during apoptosis induction are not known. We have shown previously that the cyclin-dependent kinase 1/cyclin B (cdk1/CyB or cdc2/CyB) complex phosphorylates IP3R1 in vitro and in vivo at Ser421 and Thr799. In this study, we show that: 1) the cdc2/CyB complex directly interacts with IP3R1 through Arg 391, Arg441, and Arg871; 2) IP3R1 phosphorylation at Thr799 by the cdc2/CyB complex increases IP 3 binding; and 3) cdc2/CyB phosphorylation increases IP 3-gated Ca2+ release. Taken together, these results demonstrate that cdc2/CyB phosphorylation positively regulates IP 3-gated Ca2+ signaling. In addition, identification of a CyB docking site(s) on IP3R1 demonstrates, for the first time, a direct interaction between a cell cycle component and an intracellular calcium release channel. Blocking this phosphorylation event with a specific peptide in inhibitor(s) may constitute a new therapy for the treatment of several human immune disorders.
UR - http://www.scopus.com/inward/record.url?scp=27144469837&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.175.9.6205
DO - 10.4049/jimmunol.175.9.6205
M3 - Article
C2 - 16237118
AN - SCOPUS:27144469837
SN - 0022-1767
VL - 175
SP - 6205
EP - 6210
JO - Journal of Immunology
JF - Journal of Immunology
IS - 9
ER -